Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
0.3418
-0.0262 (-7.12%)
At close: Jul 7, 2026
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $15.01 million as of July 7, 2026. Its market cap has decreased by -76.88% in one year.
Market Cap
15.01M
Enterprise Value
5.97M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.34
Market Cap Chart
Since May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from 165.19M to 15.01M, a decrease of -90.91%. That is a compound annual growth rate of -37.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 15.01M | -63.83% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -13.09% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 21.21M |
| Oncotelic Therapeutics | 17.60M |
| Finch Therapeutics Group | 16.86M |
| Zenith Capital | 15.97M |
| Galera Therapeutics | 14.28M |
| Zeo ScientifiX | 14.19M |
| Inhibitor Therapeutics | 13.64M |
| Brainstorm Cell Therapeutics | 13.61M |